|Articles|February 2, 2005

2005 ACT Directory & Buyers Guide

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© photon_photo - © photon_photo - stock.adobe.com

Getting Clinical Outsourcing Right

ByHenry Galio

November 12th 2025

Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2

ByAndy Studna, Senior Editor

November 12th 2025

ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes

ByAndy Studna, Senior Editor

November 12th 2025

Modernizing Recruitment with Data, HCP Networks, and Last Mile Support

ByMatt Holms,Andy Studna, Senior Editor

November 12th 2025

Decision Inputs in Drug Development—Big Vs. Small Pharma: Is There a Difference?

ByPartha Anbil,Jayanthi Anbil

November 11th 2025

2005 ACT Directory & Buyers Guide

Newsletter

Related Content

Getting Clinical Outsourcing Right

Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2

ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes

Modernizing Recruitment with Data, HCP Networks, and Last Mile Support

Decision Inputs in Drug Development—Big Vs. Small Pharma: Is There a Difference?

Trending on Applied Clinical Trials Online

Modernizing Recruitment with Data, HCP Networks, and Last Mile Support

Getting Clinical Outsourcing Right

ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes

Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2

Decision Inputs in Drug Development—Big Vs. Small Pharma: Is There a Difference?